Depressed Levels of Ca2+-Cycling Proteins May Underlie Sarcoplasmic Reticulum Dysfunction in the Diabetic Heart
- 1 September 2001
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 50 (9) , 2133-2138
- https://doi.org/10.2337/diabetes.50.9.2133
Abstract
In view of the depressed sarcoplasmic reticulum (SR) Ca2+-pump and Ca2+-release activities in the diabetic heart and the critical role of phosphorylation in regulating the SR function, we examined the status of Ca2+-calmodulin–dependent protein kinase (CaMK) and cAMP-dependent protein kinase (PKA)-mediated phosphorylations in the diabetic heart. Diabetes was induced in male Sprague-Dawley rats by an injection of streptozotocin (65 mg/kg i.v.), and the animals were killed 6 weeks later for assessment of the ventricular SR function. Depressed cardiac performance and SR Ca2+-uptake and -release activities in diabetic animals were accompanied by a significant decrease in the level of SR Ca2+-cycling proteins, such as ryanodine receptor, Ca2+-pump ATPase, and phospholamban. On the other hand, the CaMK- and PKA-mediated phosphorylations of these Ca2+-cycling proteins, the endogenous SR CaMK and PKA activities, and the endogenous SR and cytosolic phosphatase activities were increased in the diabetic heart. Treatment of 3-week diabetic animals with insulin partially or fully prevented the diabetes-induced changes in cardiac performance, SR Ca2+-uptake and -release activites, and SR protein content, whereas the diabetes-induced changes in SR CaMK- and PKA-mediated phosphorylations and activities, as well as phosphatase activities, were not significantly affected. These results suggest that the reduced content of the Ca2+-cycling proteins, unlike alterations in PKA and phosphatase activities, appear to be the major defect underlying SR dysfunction in the diabetic heart.Keywords
This publication has 30 references indexed in Scilit:
- PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor): Defective Regulation in Failing HeartsPublished by Elsevier ,2000
- Diminished Expression of Sarcoplasmic Reticulum Ca2+-ATPase and Ryanodine Sensitive Ca2+Channel mRNA in Streptozotocin-induced Diabetic Rat HeartJournal of Molecular and Cellular Cardiology, 2000
- Increased expression of Gαq protein in the heart of streptozotocin-induced diabetic ratsExperimental & Molecular Medicine, 1999
- The max of the Ca2+-ATPase of Cardiac Sarcoplasmic Reticulum (SERCA2a) Is Not Altered by Ca2+/Calmodulin-dependent Phosphorylation or by Interaction with PhospholambanPublished by Elsevier ,1996
- Protein Phosphorylation and Dephosphorylation in Physiologic and Oncologic ProcessesCritical Reviews™ in Oncogenesis, 1996
- The cardiac sarcoplasmic reticulum phospholamban kinase is a distinct δ‐CaM kinase isozymeFEBS Letters, 1995
- Cardiac Sarcoplasmic Reticulum Ca2+-ATPase Expression in Streptozotocin-Induced Diabetic Rat HeartBiochemical and Biophysical Research Communications, 1994
- Depression of calcium transport in sarcoplasmic reticulum from diabetic rats: Lack of involvement by specific regulatory mediatorsGeneral Pharmacology: The Vascular System, 1984
- The effect of alloxan- and streptozotocin-induced diabetes on calcium transport in rat cardiac sarcoplasmic reticulum. The possible involvement of long chain acylcarnitinesCanadian Journal of Physiology and Pharmacology, 1983
- Characterization of cyclic 3′:5′-AMP-dependent protein kinase in sarcoplasmic reticulum and cytosol of canine myocardiumBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982